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Abstract 
The prevalence of type 2 diabetes mellitus has reached epidemic proportions worldwide. 
Several single-nucleotide polymorphisms (SNPs) investigated in the genes of insulin signaling 
pathway have been associated with type 2 diabetes. We investigated three single nucleotide 
polymorphisms at codon 233, 234 and 276 in exon 3 of insulin receptor gene in type 2 diabetic 
patients of Kashmir valley. 468 subjects comprising of 198 type 2 diabetic cases and 270 non 
diabetic controls were included in the study. PCR-RFLP technique was used for 
genotyping.Amplified products were digested withMspI, RsaI and FokI restriction enzymes. 
Results were validated by direct sequencing of amplicons. All the subjects were monomorphic 
as no genotypic or allelic variation was observed in either cases or controls. Our study 
elucidates that substitutions at codon 233, 234 and 276 in exon 3 of insulin receptor gene do 
not occur in our population and thereby has no role in conferring any risk or genetic 
predisposition towards development of type 2 diabetes. 
 
